June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Long Term Outcomes of Surgical Bleb Revision of Failed Trabeculectomy
Author Affiliations & Notes
  • Doaa Sobeih
    Ophthalmology, Lahey Clinic Hospital, Burlington, MA
  • Paul Cotran
    Ophthalmology, Lahey Clinic Hospital, Burlington, MA
    Tufts Medical School, Boston, MA
  • Footnotes
    Commercial Relationships Doaa Sobeih, None; Paul Cotran, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2728. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Doaa Sobeih, Paul Cotran; Long Term Outcomes of Surgical Bleb Revision of Failed Trabeculectomy. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2728.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To investigate the long term clinical outcomes of surgical revision of failed trabeculectomy using a limbus based incision and Mitomycin C (MMC).

Methods: A retrospective chart review of all patients who underwent surgical revision to restore the function of a failed trabeculectomy between 2007 and 2014. Of the sixty-five eyes operated 59 originally had trabeculectomy with MMC and 6 originally had phacotrabeculectomy with MMC. All cases were performed by one surgeon (PRC). The technique involved a conjunctival incision 8 mm posterior to the limbus, conjunctival elevation, resection of scar tissue overlying the scleral flap, application of 0.4 mg/ml of MMC, and reopening of the original scleral flap and sclerostomy. This was followed by suturing of the scleral flap and conjunctival wound. Frequency application of topical steroids, laser suture lysis, and other techniques were employed as needed in the postoperative period to maintain function of the reformed filtering blebs.

Results: Sixty-five eyes of sixty patients underwent surgical bleb revision of failed trabeculectomies with MMC. Mean IOP was significantly reduced from 21.0±7.8 mmHg preoperatively to 11.4±5.1 mmHg at 1 year (p value < 0.0001), to 10.4±4.7 mmHg at 2 years (p value < 0.0001), to 10.9±4.6 mmHg at 3 years, and to 10.1±3.7 mmHg at 5 years (p value < 0.0001). The number of the glaucoma medications used was reduced from 2.38 0.68 to 0.55± 0.68 at 1 year (p value < 0.0001), 0.76± 0.75 at 3 years (p value < 0.0001), and 0.76± 0.77 at 5 years after surgery (p value < 0.0001). By Kaplan-Meier survival analysis, the overall cumulative success rates at 1, 3, 6, 12, and 24 months were 84.6%, 83.1%, 81.3%, 75.6%, and 68% respectively. .Four cases required a second procedure (7%), transient choroidal effusions occurred in 4 eyes (7%), corneal decompensation in 1 eye (1.7%), and ptosis in 1 (1.7%).<br />

Conclusions: Surgical bleb revision is an effective and safe surgery for long term control of IOP following failed trabeculectomy. It is an excellent alternative to a tube shunt procedure or repeat trabeculectomy in appropriately selected cases.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.